Key result
Invasive coronary revascularization was associated with lower PTSD symptoms at 1 month compared to medical management in patients with first ACS (B = -5.32; 95% CI -9.77 to -0.87; p=0.020).
Why the study?
To evaluate the enduring somatic threat model of PTSD by testing whether invasive coronary revascularization reduces threat perceptions and subsequent PTSD symptoms compared to medical management in first ACS patients.
Does invasive coronary revascularization reduce PTSD symptoms in patients with first acute coronary syndrome compared to medical management?
Population
143 patients enrolled during their first ACS
Comparison
Revascularized vs catheterized without revascularization vs medically managed
Design
Cohort study
Follow-up
1 month
Authors
Loading...
EST model offers framework for post-ACS PTSD; leaves open whether targeting somatic cues improves outcomes.
Cohort (n=143)
Does invasive coronary revascularization reduce PTSD symptoms in patients with first acute coronary syndrome compared to medical management?
Mean Difference: -5.32 (95% CI -9.77–-0.87)
p-value: p=0.020
Invasive coronary revascularization may reduce PTSD symptoms compared to medical management in patients with first ACS, supporting the enduring somatic threat model.
Edmondson et al. (2018) conducted a cohort in First acute coronary syndrome (ACS) (n=143). Invasive coronary revascularization vs. Medical management was evaluated on PTSD symptoms at 1 month (B = -5.32, 95% CI -9.77 to -0.87, p=0.020). Invasive coronary revascularization was associated with lower PTSD symptoms at 1 month compared to medical management in patients with first ACS (B = -5.32; 95% CI -9.77 to -0.87; p=0.020).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: